Page 40 - French Code News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The United Mexican States Announces Tender Results News provided by Share this article Mexico") previously announced an offer to purchase for cash (the " Tender Offer") its outstanding notes of series set forth in the table below (collectively, the " Old Notes"), on the terms and subject to the conditions contained in the Offer to Purchase, dated January 14, 2021 (the " Offer to Purchase"). Mexico has instructed Citigroup Global Markets Inc., as the billing and delivering bank for the Tender Offer, to accept, subject to proration and other terms and conditions contained in the Offer to Purch...

ATASCADERO, Calif., Jan. 14, 2021 /PRNewswire-PRWeb/ -- Atascadero State Farm Insurance Agent, John Donovan, recently announced insurance solutions to help

The United Mexican States Announces New Notes Offering and Tender Offer News provided by Share this article New Notes Offering New Notes Offering") of its global notes to be denominated in euros due 2033 (the " 2033 New Notes") and its global notes to be denominated in euros due 2051 (" 2051 New Notes," and together with the 2033 New Notes, the " New Notes"). The New Notes offered may include New Notes that may be issued and sold to certain tendering holders in the Tender Offer (as described below). Banco Santander, S.A., Barclays Bank PLC, BNP Paribas and Citigroup Global Markets Limited wil...

NANOBIOTIX Announces Closing of Global Offering and Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to $113.3 Million Nanobiotix's ADSs began trading on the Nasdaq Global Select Market on December 11, 2020. Announced full exercise of underwriters' option to purchase additional American Depositary Shares (ADSs), with closing expected to take place on December 18, 2020. Will add approximately $14.8 million in additional gross proceeds for total of $113.3 million in gross proceeds from the offering. Regulatory News: NANOBIOTIX (Pa...

NANOBIOTIX (Paris:NANO) (Euronext: NANO – ISIN : FR0011341205 – the ‘‘ Company’’), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the pricing of its initial public offering on the Nasdaq Global Select Market by way of a capital increase of 7,300,000 new ordinary shares (the “ New Shares”), consisting of a public offering of 5,445,000 ordinary shares in the form of American Depositary Shares (“ ADSs”), each representing the right to receive one ordinary share, in the United States (the “ U.S. Offering”) and a ...